Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,393 | 26,142 | 30,084 | 21,482 | 21,268 |
| Marketable Securities | 70,671 | 82,321 | 77,096 | 79,836 | 75,804 |
| Receivables | 21,259 | 20,325 | 17,408 | 19,251 | 18,322 |
| Inventories | 6,077 | 5,947 | 5,980 | 5,889 | 5,438 |
| Income taxes - deferred | 3,762 | 2,941 | 2,837 | 2,818 | 2,720 |
| TOTAL | $129,078 | $138,647 | $134,169 | $130,061 | $124,192 |
| Non-Current Assets | |||||
| PPE Net | 70,313 | 63,047 | 53,377 | 50,531 | 49,194 |
| Intangibles | 18,897 | 21,034 | 23,172 | 25,309 | 27,446 |
| Other Non-Current Assets | 19,960 | 15,983 | 17,322 | 17,632 | 14,693 |
| TOTAL | $109,169 | $100,064 | $93,871 | $93,472 | $91,334 |
| Total Assets | $238,247 | $238,710 | $228,040 | $223,533 | $215,525 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 950 | 933 | 917 | 901 | 885 |
| Accounts payable and accrued liabilities | 10,806 | 8,858 | 9,009 | 8,269 | 9,632 |
| Accrued Expenses | 2,874 | 2,474 | 1,898 | 2,022 | 2,303 |
| TOTAL | $14,630 | $14,716 | $13,835 | $16,532 | $15,892 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,101 | 17,342 | 17,586 | 17,822 | 18,050 |
| Other Non-Current Liabilities | 0 | 981 | 1,962 | 2,942 | 3,923 |
| TOTAL | $17,101 | $18,323 | $19,547 | $20,764 | $21,973 |
| Total Liabilities | $31,730 | $33,039 | $33,382 | $37,296 | $37,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,308 | 166,287 | 166,041 | 165,998 | 165,775 |
| Common Shares | 416 | 416 | 415 | 414 | 414 |
| Retained earnings | 147,369 | 147,933 | 137,359 | 129,122 | 121,210 |
| Other shareholders' equity | 148 | -1,258 | -913 | -725 | -1,346 |
| TOTAL | $206,517 | $205,671 | $194,658 | $186,237 | $177,660 |
| Total Liabilities And Equity | $238,247 | $238,710 | $228,040 | $223,533 | $215,525 |